Through an innovation awards program, the Robert J. and Nancy D. Carney Institute for Brain Science will provide $564,000 in seed funding for new high-impact research in computation, visual science, Parkinson’s disease and Alzheimer’s disease.

"I’m in a position to say, 'I can't come up with (a drug), but I can help you see if it's safe and efficacious in people.' A lot of drug development needs a pharmaceutical company. But for early proof of concept, safety, and efficacy studies, we can do that all within Brown. We can take things into the clinic."

Butler Hospital and Brown University have launched a new research study to find methods for early and accurate diagnosis of Alzheimer’s disease.

Led by principal investigator John Sedivy, a multi-university effort will build on recent discoveries about mechanisms of aging to understand causes and potential treatments for neurodegenerative diseases.

In recognition of Alzheimer’s Awareness Month, we highlight Brown research projects making an impact on Alzheimer’s disease and dementia.

Treatment, much less cure, has been elusive. Brown scientists are on the case.

Early detection. Personalized treatments. Collaborative care. The Center for Alzheimer’s Disease Research is positioning Brown to improve patient outcomes now and in the future.

By convening innovative researchers across academia, Brown’s new Center for Alzheimer’s Disease Research hopes to accelerate the pace of development for treatments and cures of this devastating disease.

Dr. Stephen Salloway, associate director of Brown’s new Center for Alzheimer’s Research who led clinical trials for the recently approved aducanumab, explained the key takeaways from the FDA’s headline-making decision.

New studies seek to get ahead of Alzheimer’s disease.

By bringing together biomedical research and discovery with world-class physician-scientists advancing care for patients with Alzheimer’s, the center aims to accelerate the pace of development for novel treatments and cures.

With $30 million in support, Brown launches Center for Alzheimer’s Disease Research

New studies seek to get ahead of Alzheimer’s disease.

By 2040, approximately one in five people in the U.S. will be 65 years old or older. As Americans are increasingly dealing with age-related diseases such as diabetes, heart disease, stroke, and Alzheimer’s, Brown researchers are trying to understand why aging occurs in an attempt to meet the country’s growing health care needs.

Deadly diseases don’t wait. Neither should good ideas. So when two undergraduates thought they’d found a way to stop neurodegeneration, they took action.